Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bedford, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Anika Therapeutics, Inc. has filed 1,096 SEC EDGAR filings since 22 Feb 1996

SEC filing history

Showing 401-425 of 768 matching filings.

Per page
25
Current page
17
4

4 filing

Filing date
06 Feb 2019
Reporting date
04 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SC 13G/A filing

Filing date
24 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SCHEDULE 13G/A

Filing date
20 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Oct 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

ANIKA THERAPEUTICS, INC. 8-K

Filing date
24 Oct 2018
Reporting date
24 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
24 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Sep 2018
Reporting date
31 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Sep 2018
Reporting date
31 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
05 Sep 2018
Reporting date
31 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

ANIKA THERAPEUTICS, INC. 8-K

Filing date
25 Jul 2018
Reporting date
25 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

ANIKA THERAPEUTICS, INC. 8-K

Filing date
19 Jun 2018
Reporting date
19 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
06 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
29 May 2018
Reporting date
24 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

ANIKA THERAPEUTICS, INC. 8-K

Filing date
02 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-14027

DEFA 14A

Filing date
17 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-14027

DEF 14A

Filing date
17 Apr 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-14027

PRE 14A

Filing date
06 Apr 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45573

SC 13G/A

Filing date
22 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14027

FORM 8-K

Filing date
08 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .